UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

Introduction Adrenal steroidogenesis is essential for human survival and depends on the availability of the precursor cholesterol. Male subjects with low plasma levels of high density lipoprotein (HDL) cholesterol are characterized by decreased adrenal function. Whether this is also the case in female subjects with low plasma HDL-c levels is unresolved to date. Methods and Results 15 female ATP binding cassette transporter AI (ABCAI) and 14 female lecithin-cholesterol acyltransferase (LCAT) were included in the study. HDL-c levels were 38% and 41% lower in ABCA1 and LCAT mutation carriers compared to controls, respectively. Urinary steroid excretion of 17-ketogenic steroids or 17-hydroxy corticosteroids did not differ between 15 female ABCA1 mutation carriers (p=0.27 vs 0.30 respectively) and 30 matched normolipidemic controls or between 14 female LCAT mutation carriers and 28 matched normolipidemic controls (p=0.10 and 0.14, respectively). Cosyntropin testing in an unselected subgroup of 8 ABCA1 mutation carriers and 3 LCAT mutation carriers did not reveal differences between carriers and controls. Conclusion Adrenal function in females with molecularly defined low HDL-c levels is not different from controls. The discrepancy with the finding of impaired steroidogenesis in males with molecularly defined low HDL-c levels underscores the importance of gender specific analyses in cholesterol-related research.

[1]  J. Romijn,et al.  High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C , 2013, Journal of Lipid Research.

[2]  Jan Albert Kuivenhoven,et al.  Genetic variant of the scavenger receptor BI in humans. , 2011, The New England journal of medicine.

[3]  W. Shen,et al.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones , 2010, Nutrition & metabolism.

[4]  N. Wareham,et al.  Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study , 2010, Journal of Lipid Research.

[5]  G. Franceschini,et al.  Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans , 2009, Circulation.

[6]  J. Kastelein,et al.  In Vivo Quantification of Carotid Artery Wall Dimensions: 3.0-Tesla MRI Versus B-Mode Ultrasound Imaging , 2009, Circulation. Cardiovascular imaging.

[7]  M. Hayden,et al.  Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction , 2008, Diabetes Care.

[8]  T. V. van Berkel,et al.  Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting Published, JLR Papers in Press, January 19, 2008. , 2008, Journal of Lipid Research.

[9]  James D. Johnson,et al.  β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment , 2007, Nature Medicine.

[10]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[11]  M. Irwin,et al.  Sex differences in the monocyte expression of IL-6: Role of autonomic mechanisms , 2006, Brain, Behavior, and Immunity.

[12]  S. Doi,et al.  Relationship between cortisol increment and basal cortisol: implications for the low-dose short adrenocorticotropic hormone stimulation test. , 2006, Clinical chemistry.

[13]  P. Marik,et al.  The hepatoadrenal syndrome: A common yet unrecognized clinical condition* , 2005, Critical care medicine.

[14]  M. Kuiper,et al.  HDL-cholesterol level and cortisol response to synacthen in critically ill patients. , 2003, Intensive care medicine.

[15]  S. Azhar,et al.  Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. , 2003, Frontiers in bioscience : a journal and virtual library.

[16]  S. Azhar,et al.  Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis , 2002, Molecular and Cellular Endocrinology.

[17]  R. Straub,et al.  Differential Male and Female Adrenal Cortical Steroid Hormone and Cortisol Responses to Interleukin‐6 in Humans , 2002, Annals of the New York Academy of Sciences.

[18]  B. McManus,et al.  ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.

[19]  A. Zwinderman,et al.  Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.

[20]  J. Puder,et al.  Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  L. Muglia,et al.  Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Wardlaw,et al.  Testosterone Suppresses the Response of the Hypothalamic-Pituitary-Adrenal Axis to Interleukin-6 , 2000, Neuroimmunomodulation.

[23]  J. Connell,et al.  Cortisol effects on body mass, blood pressure, and cholesterol in the general population. , 1999, Hypertension.

[24]  Clark,et al.  Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic‐pituitary disorders , 1998, Clinical endocrinology.

[25]  L. Blevins,et al.  The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  H. Sasano,et al.  Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. , 1998, Life sciences.

[27]  W. Scherbaum,et al.  Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. , 1997, The Journal of clinical endocrinology and metabolism.

[28]  B. Scheithauer,et al.  Biochemical evaluation of adrenal dysfunction: the laboratory perspective. , 1992, Mayo Clinic proceedings.

[29]  C. Weykamp,et al.  Steroid profile for urine: reference values. , 1989, Clinical chemistry.

[30]  S. Azhar,et al.  Utilization of cholesterol-rich lipoproteins by perfused rat adrenals. , 1989, Journal of lipid research.

[31]  J L Coolens,et al.  Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. , 1987, Journal of steroid biochemistry.

[32]  F. Leidenberger,et al.  Desensitization of mouse Leydig cells in vivo: evidence for the depletion of cellular cholesterol. , 1985, Biology of reproduction.

[33]  Y. D. Chen,et al.  Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion. , 1984, The Journal of clinical investigation.

[34]  D. Streeten,et al.  Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. , 1984, Endocrine reviews.

[35]  R. Lees,et al.  Adrenal cortical function in homozygous familial hypercholesterolemia. , 1983, Metabolism: clinical and experimental.

[36]  G. Reaven,et al.  Stimulation of lipoprotein receptors and role of lipoprotein and cellular cholesterol during gonadotropin-induced desensitization of steroidogenic response in luteinized rat ovary. , 1983, The Journal of biological chemistry.

[37]  D. Illingworth,et al.  Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH. , 1982, The Journal of laboratory and clinical medicine.

[38]  D. Illingworth,et al.  Impaired cortisol secretion in abetalipoproteinemia. , 1980, The Journal of clinical endocrinology and metabolism.

[39]  R. Chanderbhan,et al.  ACTH-induced hydrolysis of cholesteryl esters in rat adrenal cells. , 1978, Journal of lipid research.

[40]  A. Borkowski,et al.  Metabolism of adrenal cholesterol in man. I. In vivo studies. , 1972, The Journal of clinical investigation.

[41]  N. A. Schmidt,et al.  Profiling urinary steroids. A reliable procedure. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[42]  A. Mahler,et al.  Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. , 1967, The Journal of clinical investigation.

[43]  J. Kastelein,et al.  Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging Carriers , 2011 .

[44]  D. Illingworth,et al.  Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia. , 1984, The Journal of clinical endocrinology and metabolism.

[45]  D. Illingworth,et al.  Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. , 1982, The Journal of clinical endocrinology and metabolism.